1. Engineered bacteria direct the tumor-specificity of CAR-T cells to enable antigen-agonistic tumor targeting Vincent, Rosa Louise 2024 Theses ImmunologyOncologyBacterial genetic engineeringTumors--TreatmentTumors--Genetic aspectsEscherichia coli--ResearchT cellsLeukemia--Treatment
2. Functional characterization and multi-factor analysis of exhaustion in chronic lymphocytic leukemia T cells Lee, Joanne Haeun 2021 Theses Biomedical engineeringLeukemia--TreatmentAntigens--ReceptorsChronic lymphocytic leukemiaHTLV (Viruses)
3. Trial and Error: The Invention of Cancer Chemotherapy 1950-1980 Levy, Moran 2020 Theses Social sciences--ResearchHistoryOncologyChemotherapyLeukemia--Treatment
4. Bridging the Gap Between Our Understanding of AML Pathogenesis and the Development of Targeted Therapies Tavakkoli, Montreh 2014 Theses Leukemia--TreatmentCarcinogenesisAcute myeloid leukemiaOncologyEpidemiology
5. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia? Subramaniyam, Shivakumar; Nandula, Subhadra; Nichols, G.; Weiner, Michael A.; Satwani, Prakash; Alobeid, Bachir; Bhagat, Govind; Vundavalli, Murty V. 2006 Articles LeukemiaLeukemia--TreatmentDrug resistance in cancer cellsGene fusionGenetics